Clinical trial
An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate
NCT00358722 · Ineos Healthcare Limited, Industry · Terminated
Key facts
| NCT number | NCT00358722 |
|---|---|
| Title | An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate |
| Official title | A Long-term, Open-label Continuation Study to Assess the Safety of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia |
| Acronym | ALCON |
| Lead sponsor | Ineos Healthcare Limited, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Kidney Failure |
| Intervention type | Drug |
| Interventions | Fermagate |
| Enrollment | 44 |
| Start date | Jul 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Aug 1, 2006 |
| Last update posted | Aug 10, 2009 |
| Countries | United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: